跳至主要内容
临床试验/NCT06572579
NCT06572579已完成不适用

Safety and Effectiveness of Ultrasound-guided Pharmacopuncture for Spinal Diseases: A Pilot Registry

Jaseng Medical Foundation3 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2024年9月23日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
50
试验地点
3
主要终点
Adverse Event

研究概览

简要总结

A pilot study of prospective resigstry to evaluate the safety and efficacy of ultrasound-guided pharmacopuncture for spinal disorders

详细描述

This study aims to evaluate the safety and efficacy of ultrasound-guided pharmacopuncture by collecting information on adverse reactions, efficacy assessment variables, and treatment methods from patients diagnosed with spinal disorders who have undergone ultrasound-guided pharmacopuncture treatment.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
19 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Individuals diagnosed with spinal disorders (M code and S code based on KCD criteria)
  • Outpatients scheduled for ultrasound-guided pharmacopuncture treatment
  • Individuals aged 19 years or older and under 70 years
  • Individuals who agree to participate in the clinical study and voluntarily sign the consent form

排除标准

  • Individuals who are unable to complete the consent form
  • Individuals who are deemed unsuitable for participation in the clinical study by the researcher

结局指标

主要结局

Adverse Event

时间窗: Treatment visits up to 12 weeks, and Week 2, 4, 8, 12 follow-ups

Adverse events assessment

次要结局

  • EQ-5D-5L(Week 0, 2, 4, 8, 12)
  • Patient satisfaction(Week 4)
  • Spinal pain numeric rating scale(Week 0, Treatment visits up to 12 weeks, and Week 2, 4, 8, 12 follow-ups)
  • Disability index(Week 0, 2, 4, 8, 12)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验

A Pilot Registry for Ultrasound-guided... | 临床试验